123 related articles for article (PubMed ID: 21273787)
21. Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets.
Kumar R; Balhuizen A; Amisten S; Lundquist I; Salehi A
Endocrinology; 2011 Jul; 152(7):2568-79. PubMed ID: 21521748
[TBL] [Abstract][Full Text] [Related]
22. Is the membrane estrogen receptor, GPER1, a promiscuous receptor that modulates nuclear estrogen receptor-mediated functions in the brain?
Vajaria R; Vasudevan N
Horm Behav; 2018 Aug; 104():165-172. PubMed ID: 29964007
[TBL] [Abstract][Full Text] [Related]
23. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
24. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
[TBL] [Abstract][Full Text] [Related]
25. Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach.
Notas G; Kampa M; Pelekanou V; Castanas E
Steroids; 2012 Aug; 77(10):943-50. PubMed ID: 22138208
[TBL] [Abstract][Full Text] [Related]
26. 17β-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1.
Jiang QF; Wu TT; Yang JY; Dong CR; Wang N; Liu XH; Liu ZM
J Steroid Biochem Mol Biol; 2013 Nov; 138():314-24. PubMed ID: 23907016
[TBL] [Abstract][Full Text] [Related]
27. Ceramide synthases CerS4 and CerS5 are upregulated by 17β-estradiol and GPER1 via AP-1 in human breast cancer cells.
Wegner MS; Wanger RA; Oertel S; Brachtendorf S; Hartmann D; Schiffmann S; Marschalek R; Schreiber Y; Ferreirós N; Geisslinger G; Grösch S
Biochem Pharmacol; 2014 Dec; 92(4):577-89. PubMed ID: 25451689
[TBL] [Abstract][Full Text] [Related]
28. Immunolocalization of G Protein-Coupled Estrogen Receptor in the Pig Epididymis.
Malivindi R; Aquila S; Rago V
Anat Rec (Hoboken); 2018 Aug; 301(8):1467-1473. PubMed ID: 29679442
[TBL] [Abstract][Full Text] [Related]
29. Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor1 (GPER-1) agonist, in the isolated perfused rat kidney.
Kurt AH; Buyukafsar K
Eur J Pharmacol; 2013 Feb; 702(1-3):71-8. PubMed ID: 23376418
[TBL] [Abstract][Full Text] [Related]
30. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
31. Estrogen stabilizes hypoxia-inducible factor 1α through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis.
Zhang L; Xiong W; Li N; Liu H; He H; Du Y; Zhang Z; Liu Y
Fertil Steril; 2017 Feb; 107(2):439-447. PubMed ID: 27939762
[TBL] [Abstract][Full Text] [Related]
32. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
[TBL] [Abstract][Full Text] [Related]
33. GPER1 stimulation alters posttranslational modification of RGSz1 and induces desensitization of 5-HT1A receptor signaling in the rat hypothalamus.
McAllister CE; Mi Z; Mure M; Li Q; Muma NA
Neuroendocrinology; 2014; 100(2-3):228-39. PubMed ID: 25402859
[TBL] [Abstract][Full Text] [Related]
34. Icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway.
Ma HR; Wang J; Chen YF; Chen H; Wang WS; Aisa HA
Int J Mol Med; 2014 Jun; 33(6):1627-34. PubMed ID: 24718680
[TBL] [Abstract][Full Text] [Related]
35. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion.
Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC
PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837
[TBL] [Abstract][Full Text] [Related]
36. G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments.
Sandén C; Broselid S; Cornmark L; Andersson K; Daszkiewicz-Nilsson J; Mårtensson UE; Olde B; Leeb-Lundberg LM
Mol Pharmacol; 2011 Mar; 79(3):400-10. PubMed ID: 21149639
[TBL] [Abstract][Full Text] [Related]
37. GPER1/GPR30 in the brain: Crosstalk with classical estrogen receptors and implications for behavior.
Hadjimarkou MM; Vasudevan N
J Steroid Biochem Mol Biol; 2018 Feb; 176():57-64. PubMed ID: 28465157
[TBL] [Abstract][Full Text] [Related]
38. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Broselid S; Cheng B; Sjöström M; Lövgren K; Klug-De Santiago HL; Belting M; Jirström K; Malmström P; Olde B; Bendahl PO; Hartman L; Fernö M; Leeb-Lundberg LM
Clin Cancer Res; 2013 Apr; 19(7):1681-92. PubMed ID: 23554355
[TBL] [Abstract][Full Text] [Related]
39. Estrogen signaling through estrogen receptor beta and G-protein-coupled estrogen receptor 1 in human cerebral vascular endothelial cells: implications for cerebral aneurysms.
Tu J; Jufri NF
Biomed Res Int; 2013; 2013():524324. PubMed ID: 24319683
[TBL] [Abstract][Full Text] [Related]
40. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
